Latest / The Well-Built Life / Beyond Cholesterol: The New Quest to Outsmart Heart Disease
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:17Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:21Speaker 1: and let's dive in. Dr. Philip Ovadius' journey from the
- 0:25Speaker 1: operating room to the kitchen is quite a compelling narrative.
- 0:29Speaker 1: Let's dive into what sparked his transformation from a heart
- 0:32Speaker 1: surgeon focused on traditional surgery to a prevention specialist advocating
- 0:38Speaker 1: for metabolic health.
- 0:39Speaker 2: Absolutely. It all started around the turn of the millennium
- 0:43Speaker 2: when Dr. Ovadia was still in medical school in 1998.
- 0:47Speaker 2: Fast forward to the 2010s, cholesterol had long been the
- 0:51Speaker 2: conventional wisdom for heart disease. But then you know what happened?
- 0:55Speaker 2: Gary Tobey asks, the case against sugar blew the lid
- 0:58Speaker 2: off things.
- 0:59Speaker 1: Exactly. Sugar and its link to insulin resistance became a
- 1:02Speaker 1: game changer. Around this time, Dr. Ovadia, attending a Society
- 1:07Speaker 1: of Thoracic Surgeons conference, had the chance to hear Tobey speak.
- 1:12Speaker 1: This event seems to have been pivotal.
- 1:14Speaker 2: It was. After that conference, Dr. Ovadia began diving deep
- 1:18Speaker 2: into insulin resistance and its connection to metabolic health. He
- 1:23Speaker 2: saw his patients struggling with conditions that couldn't be fully
- 1:26Speaker 2: addressed by surgery. This shift in his professional focus from
- 1:30Speaker 2: the operating table to prevention was more than just a
- 1:32Speaker 2: change in perspective. It was a fundamental rethinking of how
- 1:36Speaker 2: to treat heart disease. Right.
- 1:39Speaker 1: And that's the crucial nuance here. Dr. Ovadia's move from
- 1:43Speaker 1: surgery to prevention underscores the importance of addressing the root
- 1:47Speaker 1: causes of arterial issues rather than just treating the symptoms.
- 1:52Speaker 1: His work led to a four-step protocol that addresses the
- 1:56Speaker 1: endothelial lining, glucose levels, inflammation, and vitamins K2 and D3.
- 2:03Speaker 2: Wait, but how does that actually play out in practice?
- 2:07Speaker 2: For instance, vitamin K2S role in calcium management to prevent
- 2:11Speaker 2: calcification and D3S role in bone health. Dr. Ovadia's protocol
- 2:18Speaker 2: suggests a holistic approach that isn't just about cutting out sugar.
- 2:22Speaker 2: but also considering the broader nutritional landscape.
- 2:25Speaker 1: Exactly. Dr. Ovidius' research and personal health experiences led him
- 2:30Speaker 1: to advocate for a four-step protocol that includes reducing inflammation,
- 2:35Speaker 1: addressing vitamin deficiencies, and ensuring proper calcium management. It's fascinating
- 2:40Speaker 1: to see how these principles translate into practical advice for
- 2:45Speaker 1: reducing plaque and calcium in the arteries.
- 2:48Speaker 2: That's wild when you look at the raw numbers. Studies
- 2:51Speaker 2: show a 21 to 24.5% reduction in hard plaque and
- 2:56Speaker 2: a 71.6% reduction in adverse events. These aren't just anecdotes.
- 3:02Speaker 2: They are tangible results that challenge the conventional wisdom of
- 3:05Speaker 2: heart disease prevention.
- 3:07Speaker 1: All right, let's dive into the nitty gritty. Thomas, can
- 3:11Speaker 1: we start with the endothelial damage? I have always been
- 3:14Speaker 1: fascinated by how small this can be. yet it sets
- 3:18Speaker 1: the stage for atherosclerosis.
- 3:20Speaker 2: Exactly, and that's the crucial nuance here. Think of it
- 3:24Speaker 2: like a leaky roof. Small holes at first, but over
- 3:28Speaker 2: time they become bigger, more porous, and eventually lead to
- 3:31Speaker 2: a catastrophic failure. The endothelium, the inner lining of blood vessels,
- 3:36Speaker 2: starts to degrade due to factors like high blood glucose
- 3:39Speaker 2: and chronic inflammation. Once these gaps form, lipoproteins, particularly the
- 3:45Speaker 2: small dense LDL particles, can squeeze through initiating the first
- 3:48Speaker 2: step in the process.
- 3:50Speaker 1: Right. And this is where cholesterol gets dragged into the story.
- 3:54Speaker 1: Once these LDL particles are oxidized, it's like they have
- 3:57Speaker 1: been tainted. The immune system doesn't know if it's a
- 4:01Speaker 1: threat or a friend, so it sends macrophages to clear
- 4:04Speaker 1: them out. When these cells engulf the damaged LDL, they
- 4:08Speaker 1: become foam cells, essentially, Little scavenger trucks full of cholesterol.
- 4:13Speaker 2: And that's the beginning of the plaque formation. But it's
- 4:16Speaker 2: not just about the oxysterols and foam cells. Therese, a
- 4:20Speaker 2: fascinating dynamic at play here involving vitamins K and D.
- 4:25Speaker 2: They act as the cleanup crew for calcium, ensuring it
- 4:28Speaker 2: doesn't just build up willy, nilly, and soft tissues. One
- 4:32Speaker 2: key player is vitamin K2, which helps direct calcium where
- 4:36Speaker 2: it should go. like the bones and teeth, instead of
- 4:39Speaker 2: into the arteries. That's wild when you look at the
- 4:42Speaker 2: raw numbers. But it goes beyond just the numbers. It's
- 4:46Speaker 2: about understanding the root causes, like insulin resistance and chronic inflammation,
- 4:52Speaker 2: and treating them. Dr. Ovadia's protocol isn't just about lowering cholesterol.
- 4:57Speaker 2: It's about managing vitamin deficiencies and ensuring proper calcium use.
- 5:02Speaker 2: It's a holistic approach that's been proven effective.
- 5:05Speaker 1: Exactly. It's like shifting gears from a slow, steady climb
- 5:10Speaker 1: to a fast, controlled sprint. You are right, Thomas. The
- 5:14Speaker 1: mechanics are complex, but the takeaways are clear. We need
- 5:18Speaker 1: to prioritize reducing inflammation, addressing vitamin deficiencies, and ensuring proper
- 5:24Speaker 1: calcium management. It's not just a shift in mindset, but
- 5:28Speaker 1: a shift in how we practice medicine and live our lives.
- 5:32Speaker 1: All right, let's dive into the numbers. Thomas, can we
- 5:36Speaker 1: look at the stakeholder dynamics here? Dr. Ovadia's protocols are
- 5:41Speaker 1: not just about his interventions. Therese, a whole world of
- 5:44Speaker 1: players involved, vitamin manufacturers, public health advocates, and more. How
- 5:50Speaker 1: does this impact their strategies and approaches?
- 5:52Speaker 2: Exactly, and that's the crucial nuance here. Let's start with
- 5:56Speaker 2: vitamin manufacturers. They have historically marketed their products as quick
- 6:01Speaker 2: fixes for heart health. Dr. Ovadius' focus on vitamins K2
- 6:05Speaker 2: and D3 is in direct competition with their traditional cholesterol,
- 6:09Speaker 2: lowering supplements. How do they respond to the data showing
- 6:13Speaker 2: the efficacy of these vitamins? Right.
- 6:16Speaker 1: Take vitamin D3, for instance. It's recommended at 10,000 IU
- 6:20Speaker 1: per Dalton Y. That's a significant dosage that challenges the
- 6:24Speaker 1: conventional wisdom of 400 to 800 IU a day. and
- 6:29Speaker 1: then Therese the ratio with vitamin K2 to 100 micrograms
- 6:33Speaker 1: for every 10,000 IU of D3. It's a very specific
- 6:37Speaker 1: formula that vitamin companies are now scrambling to meet. How
- 6:42Speaker 1: is this shifting their business models?
- 6:44Speaker 2: It's wild when you look at the raw numbers. In
- 6:47Speaker 2: just three years, Therese been a 21% reduction in hard
- 6:51Speaker 2: plaque in a randomized control trial. Another trial reported a 24.5% reduction.
- 6:58Speaker 2: That sort of dramatic improvement is hard to ignore. It's
- 7:01Speaker 2: making public health advocates and vitamin manufacturers rethink their approaches.
- 7:06Speaker 2: They now have to navigate the balance between public health
- 7:09Speaker 2: priorities and their business interests.
- 7:12Speaker 1: Exactly. And this is where the dynamic between public health
- 7:15Speaker 1: advocates and vitamin manufacturers gets really interesting. Public health advocates
- 7:20Speaker 1: are pushing for comprehensive interventions to address metabolic health. They
- 7:25Speaker 1: are likely lobbying for policies that support dietary guidelines and
- 7:29Speaker 1: supplementation recommendations. Meanwhile, vitamin manufacturers are under pressure to develop
- 7:35Speaker 1: and market products that align with Dr. Ovadia's findings. How
- 7:39Speaker 1: are these stakeholders aligning their efforts or conflicting with each other?
- 7:44Speaker 2: That's a great point, Rachel. The conflict is apparent. On
- 7:48Speaker 2: one hand, public health advocates are promoting preventive measures, diet,
- 7:52Speaker 2: and lifestyle changes. They support the idea that a holistic
- 7:55Speaker 2: approach is necessary. On the other hand, vitamin manufacturers are
- 8:00Speaker 2: investing heavily in D3 and K2 because of the data.
- 8:04Speaker 2: They are running expensive campaigns to educate consumers and healthcare
- 8:08Speaker 2: providers about the importance of these vitamins. It's a complex
- 8:12Speaker 2: interplay of interests and priorities.
- 8:14Speaker 1: So, let's dive into this critical debate. Traditionally, heart disease
- 8:19Speaker 1: was largely framed within the context of high cholesterol. But
- 8:23Speaker 1: recent paradigms suggest that metabolic health, especially insulin resistance, plays
- 8:28Speaker 1: an even more critical role. How do you see this
- 8:32Speaker 1: shift impacting the healthcare landscape?
- 8:34Speaker 2: That's a compelling question, Rachel. The shift is indeed profound.
- 8:38Speaker 2: For instance, in the late 2000s, when Gary Taubes started
- 8:42Speaker 2: writing about insulin resistance, the focus was still predominantly on cholesterol. Now,
- 8:48Speaker 2: We see a more nuanced view, where factors like inflammation,
- 8:52Speaker 2: insulin levels, and even vitamin deficiencies contribute significantly. This not
- 8:58Speaker 2: only affects how doctors approach treatment, but also patient behavior.
- 9:02Speaker 1: Exactly. And it's not just about the science. The adoption
- 9:05Speaker 1: of these new paradigms is fraught with challenges. For one,
- 9:09Speaker 1: there are significant gaps in training for doctors who were
- 9:12Speaker 1: taught the old ways. How do we reconcile this with
- 9:15Speaker 1: the real-world impact?
- 9:16Speaker 2: It's a complex issue. Consider the vitamin manufacturers who are
- 9:20Speaker 2: pushing their products based on mounting evidence. They are effectively
- 9:25Speaker 2: challenging the entrenched beliefs and practices of traditional medicine. This
- 9:30Speaker 2: doesn't just affect who gets prescribed vitamins. It's a broader
- 9:34Speaker 2: push for preventive health.
- 9:35Speaker 1: Right. And to raise the consumer responsibility angle, with so
- 9:40Speaker 1: much information available, individuals are often left to navigate a
- 9:44Speaker 1: bewildering array of advice. How do you think consumers should
- 9:48Speaker 1: approach this?
- 9:48Speaker 2: Consumers face a daunting task. They need to be informed
- 9:52Speaker 2: and critical. But often, they rely on fragmented advice or
- 9:56Speaker 2: sensational headlines. It's essential for both experts and consumers to
- 10:01Speaker 2: engage in a more transparent dialogue. Maybe we need to
- 10:04Speaker 2: see more grassroots movements that combine professional insights with public education.
- 10:10Speaker 1: Agreed. And on another front, vitamin manufacturers often run campaigns
- 10:15Speaker 1: that can be seen as aggressive. They emphasize consumer choice.
- 10:19Speaker 1: but it raises questions about balanced information. How do healthcare
- 10:23Speaker 1: providers deal with this marketing?
- 10:25Speaker 2: They have to maintain a delicate balance. On one hand,
- 10:28Speaker 2: they need to be aware of these campaigns and their influence.
- 10:32Speaker 2: On the other, they must advocate for evidence-based treatments that
- 10:35Speaker 2: go beyond just supplements. It's about empowering patients to make
- 10:39Speaker 2: informed decisions, not just following fads.
- 10:42Speaker 1: Exactly. And the stakes are high. Getting it wrong can
- 10:45Speaker 1: lead to significant health issues. It's a fine line between
- 10:49Speaker 1: pushing for innovation and maintaining traditional standards. How do we
- 10:54Speaker 1: strike that balance?
- 10:55Speaker 2: We need a multifaceted approach. It starts with rigorous research
- 10:59Speaker 2: and clinical trials, but it also involves educating both healthcare
- 11:03Speaker 2: professionals and the public. Perhaps more importantly, it's understanding that
- 11:08Speaker 2: the solution isn't a one-size-fits-all approach. It's about personalized, evidence-based care.
- 11:14Speaker 1: In the end, it's about creating a balanced ecosystem. where
- 11:17Speaker 1: all stakeholders, from vitamin manufacturers to public health advocates, can
- 11:22Speaker 1: work together. This will take time, but it's essential for
- 11:26Speaker 1: moving towards a culture of true wellness. As we move forward,
- 11:30Speaker 1: let's talk about the future outlook. You know, the current
- 11:33Speaker 1: research is still unfolding, and we have a lot of
- 11:36Speaker 1: ground to cover.
- 11:37Speaker 2: Absolutely, and it's fascinating to see how far we have come,
- 11:41Speaker 2: but there is still a lot of work to do.
- 11:43Speaker 2: For instance, The role of vitamins K2 and D3 in
- 11:47Speaker 2: preventing arterial calcification is still being extensively studied. That's a
- 11:51Speaker 2: great question. I think it's about creating a broader framework
- 11:55Speaker 2: where healthcare providers and patients can collaborate. For instance, tracking
- 12:00Speaker 2: patient progress through wearable tech and apps to monitor blood glucose,
- 12:04Speaker 2: cholesterol levels, and even vitamin intake could provide valuable insights.
- 12:09Speaker 1: Exactly. Think of it as a holistic approach. But we
- 12:12Speaker 1: also have to address the challenges of adoption. How do
- 12:15Speaker 1: you make sure that both healthcare professionals and the public
- 12:19Speaker 1: can easily integrate these practices into their daily lives?
- 12:22Speaker 2: Well, it's about making it user-friendly. Educational campaigns can play
- 12:27Speaker 2: a big role, especially when they show practical, actionable steps.
- 12:32Speaker 2: For example, simple changes like increasing vitamin D and K2
- 12:36Speaker 2: intake through diet or supplementation. coupled with lifestyle modifications like exercise,
- 12:42Speaker 2: can make a significant difference.
- 12:43Speaker 1: And speaking of diet, to raise also the debate around
- 12:46Speaker 1: the impact of a low-carb diet on insulin resistance. It's
- 12:51Speaker 1: a contentious topic, and more research is needed to fully
- 12:54Speaker 1: understand its effects.
- 12:56Speaker 2: True. And this ties back into the broader public health initiatives.
- 13:00Speaker 2: We need to ensure that these interventions are not just
- 13:02Speaker 2: for the elite or the well-informed. They need to be
- 13:06Speaker 2: accessible and applicable across different socioeconomic backgrounds.
- 13:09Speaker 1: Absolutely. And that's where the future lies. We are seeing
- 13:13Speaker 1: a shift from treating symptoms to addressing root causes. But
- 13:17Speaker 1: it's a long road, and we need to stay committed
- 13:20Speaker 1: to this change.
- 13:21Speaker 2: Definitely. It's about creating a system where everyone regardless of
- 13:25Speaker 2: their background can benefit from these advancements. We are not
- 13:28Speaker 2: just talking about heart health. We are talking about overall
- 13:31Speaker 2: wellness and longevity.
- 13:33Speaker 1: Exactly. And as we conclude, let's focus on the tangible
- 13:37Speaker 1: steps we can take right now. Whether it's educating patients,
- 13:41Speaker 1: advocating for better public health policies, or simply spreading awareness,
- 13:45Speaker 1: every little bit counts. That brings us to the end
- 13:47Speaker 1: of today's episode. Thank you so much for spending part
- 13:51Speaker 1: of your day with me. If you found this episode's
- 13:53Speaker 1: tips helpful and want to make sure you don't miss
- 13:55Speaker 1: the next conversation, please take a quick second to hit
- 13:58Speaker 1: that subscribe or follow button on whatever platform you are
- 14:01Speaker 1: listening on. It's a completely free way to support the
- 14:04Speaker 1: show and helps more people find us. This podcast is
- 14:08Speaker 1: independently produced, so if you are ever in a position
- 14:11Speaker 1: where you would like to help keep it running, we
- 14:13Speaker 1: do accept small donations. You can find a link right
- 14:16Speaker 1: in the episode description below to buy us a coffee
- 14:19Speaker 1: or contribute what you can. Every bit genuinely helps. Take
- 14:24Speaker 1: care of yourself, stay balanced, and we will talk again soon.